ICD-10 Code C92.12 | Chronic myeloid leukemia, BCR/ABL-positive, in relapse Symptoms, Diagnosis, Billing

Chronic myeloid leukemia (CML) is a hematological malignancy characterized by the overproduction of myeloid cells in the bone marrow. The BCR/ABL fusion gene, resulting from a translocation between chromosomes 9 and 22, is a hallmark of this condition. In relapse, patients experience a return of symptoms after a period of remission, necessitating accurate coding with ICD-10 Code C92.12 for effective diagnosis, documentation, billing, and public health reporting.

What is ICD-10 Code C92.12 for Chronic myeloid leukemia, BCR/ABL-positive, in relapse?

ICD-10 Code C92.12 specifically denotes chronic myeloid leukemia that is BCR/ABL-positive and in a state of relapse. This code is utilized when a patient previously diagnosed with CML experiences a resurgence of the disease after treatment. Accurate use of this code in clinical documentation and billing is essential for tracking disease progression and ensuring appropriate reimbursement for healthcare services.

ICD-10 Code C92.12 – Clinical Definition and Explanation of Chronic myeloid leukemia, BCR/ABL-positive, in relapse

Chronic myeloid leukemia, BCR/ABL-positive, in relapse occurs when the disease re-emerges after a period of treatment-induced remission. The underlying cause is the presence of the BCR/ABL fusion gene, which leads to uncontrolled proliferation of myeloid cells. This condition requires prompt medical intervention due to its potential for progression to acute phases.

Key Clinical Features:

• Presence of BCR/ABL fusion gene detected via cytogenetic analysis.
• Symptoms may include fatigue, splenomegaly, and leukocytosis.
• Relapse may be indicated by an increase in blast cells in the blood or bone marrow.
• Patients may experience worsening anemia or thrombocytopenia.

ICD-10 Code C92.12 for Chronic myeloid leukemia, BCR/ABL-positive, in relapse – SOAP Notes & Clinical Use

ICD-10 Code C92.12 is integral to SOAP notes, facilitating the documentation of patient symptoms, assessments, and treatment plans. This code is relevant in both acute and chronic care settings, ensuring that healthcare providers accurately capture the patient's clinical status and treatment response.

What Does ICD-10 Code C92.12 for Chronic myeloid leukemia, BCR/ABL-positive, in relapse Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C92.12 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of chronic myeloid leukemia in relapse. This code is crucial for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code C92.12 – Chronic myeloid leukemia, BCR/ABL-positive, in relapse

Management of chronic myeloid leukemia, BCR/ABL-positive, in relapse often necessitates hospitalization for intensive treatment. Targeted therapies and supportive care are critical in managing symptoms and preventing complications.

Antibiotic Therapy:

• Imatinib (Gleevec) as first-line therapy.
• Dasatinib (Sprycel) as an alternative if resistance develops.
• Nilotinib (Tasigna) may be considered based on patient tolerance.
• Duration of therapy is typically indefinite, adjusted based on response.

Supportive Care:

• Regular monitoring of blood counts to manage cytopenias.
• Transfusions for severe anemia or thrombocytopenia.
• Hydration and nutritional support as needed.
• Psychosocial support for patients and families.

Infection Control:

• Strict hand hygiene protocols to prevent infections.
• Isolation precautions for patients with neutropenia.
• Vaccination updates as per guidelines to prevent preventable infections.
• Education on recognizing signs of infection early.

How to Document Symptoms of Chronic myeloid leukemia, BCR/ABL-positive, in relapse (ICD-10 C92.12) in SOAP Notes

Subjective:

• Patient reports increased fatigue and weakness.
• History of recurrent infections since last treatment.
• Complaints of night sweats and unexplained weight loss.
• Patient expresses concern about the return of symptoms.

Objective:

• Physical examination reveals splenomegaly.
• Complete blood count shows elevated white blood cell count.
• Bone marrow biopsy indicates increased blast cells.
• Cytogenetic analysis confirms BCR/ABL positivity.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Chronic myeloid leukemia, BCR/ABL-positive, in relapse (ICD-10 Code C92.12)

Assessment:

• Diagnosis: Chronic myeloid leukemia, BCR/ABL-positive, in relapse.
• Severity: Moderate, with evidence of increased blast cells.
• Triggers: Non-compliance with medication regimen noted.
• Complications: Risk of progression to acute leukemia.

Plan:

• Initiate treatment with Imatinib, monitor for side effects.
• Schedule regular follow-up appointments for blood work.
• Educate patient on medication adherence and symptom monitoring.
• Consider referral to a hematologist for specialized care.

Treatment & Plan Section for ICD-10 Code C92.12 – Chronic myeloid leukemia, BCR/ABL-positive, in relapse

• First-line pharmacologic treatment includes Imatinib.
• Non-pharmacologic strategies involve nutritional support and counseling.
• Monitoring practices include regular CBC and bone marrow assessments.
• Follow-up recommendations should include hematology consultations every 3 months.

Using ICD-10 Code C92.12 for Chronic myeloid leukemia, BCR/ABL-positive, in relapse in Billing & SOAP Note Compliance

• Select accurate subcodes based on clinical severity or complications.
• Document symptoms clearly under Subjective (S) and Objective (O) in SOAP notes.
• Ensure treatment plans align with clinical guidelines to support justified billing.
• Commonly billed CPT codes include 99214 for established patient visits and 85025 for complete blood counts.

Related ICD-10 Codes Often Used with Chronic myeloid leukemia, BCR/ABL-positive, in relapse

• C92.11 – Chronic myeloid leukemia, BCR/ABL-positive, in remission

ICD-10 Code C92.12 in Medical Billing and Insurance for Chronic myeloid leukemia, BCR/ABL-positive, in relapse

ICD-10 Code C92.12 is critical for accurate billing in hospital, ER, or infectious disease care settings.

Billing Notes:

• Ensure documentation includes detailed clinical findings and treatment plans.
• Use this code in conjunction with appropriate CPT codes for comprehensive billing.
• Maintain clear records of patient history and treatment response to support claims.
• Document any complications or comorbidities to justify the use of this code.

Common CPT Pairings: